Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
19 hedge funds and large institutions have $448K invested in Biolase, Inc. in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
12% more funds holding
Funds holding: 17 → 19 (+2)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
88% less capital invested
Capital invested by funds: $3.59M → $448K (-$3.14M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Prudential Financial
Newark,
New Jersey
|
+$60.7K |
| 2 |
HF
HRT Financial
New York
|
+$43.6K |
| 3 |
Renaissance Technologies
New York
|
+$35K |
| 4 |
VF
Virtu Financial
New York
|
+$34.4K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.7M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$152K |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$124K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$43K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$19.7K |
BIOL Hedge Fund Activity: Q4 2022 in Review
19 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q4 2022, worth a combined $448K — down 88% from $3.59M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BIOL positions and 4 closed out — a net gain of 2 holders — while 2 added to existing stakes and 6 trimmed.
The largest buyer was Prudential Financial, opening a new position worth an estimated $60.7K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.7M sold.
- 19 institutional investors held Biolase, Inc. (BIOL) as of Q4 2022, up from 17 in Q3 2022.
- Funds reported $448K of Biolase, Inc. stock for Q4 2022, down 88% quarter-over-quarter.
- 6 funds opened new Biolase, Inc. positions in Q4 2022 and 4 closed out, a net change of +2 holders.
- The largest Biolase, Inc. buyer in Q4 2022 was Prudential Financial, an estimated $60.7K added.
- The largest Biolase, Inc. seller in Q4 2022 was Armistice Capital, an estimated $1.7M sold.
Based on aggregated 13F filings for Q4 2022.